NOTE 3 – DISCONTINUED OPERATIONS

Through December 31, 2016, the Company’s primary business activity was the sale of various consumer products and accessories. As of January 1, 2017, the Company ceased operations. On January 19, 2017, a change in control completed as the Company’s former majority shareholder sold his 16,155,746,000 shares to an investor group. In connection with the change in control, the Company sold to its former majority shareholder one of its subsidiary for $100 and another subsidiary in exchange for the cancellation of all payables and accrued expenses. As a result, in the three months ended March 31, 2017, the Company recorded a gain on divestiture of subsidiaries of $706,076, as the subsidiaries were sold to a related party, the Company recorded the gain as a contribution to Additional Paid-in Capital. Going forward, the Company’s operations will be determined by the new investor group. As such, at March 31, 2017, the Company accounted for all of its assets, liabilities and results of operations up to January 1, 2017 as discontinued operations.

The Company has reclassified its previously issued financial statements to segregate the discontinued operations as of the earliest period reported.

Assets and liabilities related to the discontinued operations were as follows:

	March 31,			June 30,
	2017			2016
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash	$	-		$	4,669
Accounts receivable		-			2,032
Advances to suppliers		-			242,760
Other receivable		-			-
TOTAL CURRENT ASSETS	$	-		$	249,461

LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)

CURRENT LIABILITIES
Accounts payable	$	-		$	4,020
Due to related party		-			5,600
Accrued rent payable - related party		-			120,000
Advances - related party		-			34,977
Note Payable - related party		-			10,000
TOTAL CURRENT LIABILITIES		-			174,597

Deferred lease obligation - related party		-			636,154
Note payable and accrued interest - related party		-			531,975
TOTAL LIABILITIES		-			1,342,726

SHAREHOLDERS’ EQUITY (DEFICIT)
Redeemable, convertible preferred stock, 10,000,000 shares authorized; Series A voting preferred stock, zero and 500,000 shares issued and outstanding		-			500,000
Common stock, no par value, unlimited shares authorized; 20,236,021,800 and 20,056,021,800 shares issued and outstanding		-			-
Additional paid-in capital		3,062,230			550,000
Accumulated deficit		(3,062,230	)		(2,143,265	)
TOTAL SHAREHOLDERS’ EQUITY (DEFICIT)		-			(1,093,265	)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$	-		$	249,461

Revenue and expenses related to the discontinued operations were as follows:

	Three Months Ended					Nine Months Ended
	March 31,					March 31,
	2017		2016			2017			2016
	(Unaudited)					(Unaudited)

Sales	$	-	$	1,062,916		$	40,026		$	2,597,752

Cost of goods sold		-		1,159,242			28,891			2,628,033

Gross profit		-		(96,326	)		11,135			(30,281	)

Selling, general and administrative expenses:
Rent expense (related party in 2016)		-		147,692			27,786			443,077
Selling, general and administrative expenses		-		30,773			870,818			614,886
Total selling, general and administrative expenses		-		178,465			898,604			1,057,963

Loss from operations		-		(274,791	)		(887,469	)		(1,088,244	)

Other expenses
Rental income		-		15,000			-			45,300
Interest expense, related party		-		(15,058	)		(31,197	)		(39,916	)
		-		(58	)		(31,197	)		5,384

NET LOSS	$	-	$	(274,849	)	$	(918,666	)	$	(1,082,860	)

Net loss attributable to non-controlling interest		-		(1,854	)		-			(9,942	)

NET LOSS ATTRIBUTABLE TO AMERICA GREAT HEALTH	$	-	$	(272,995	)	$	(918,666	)	$	(1,072,918	)

BASIC AND DILUTED LOSS PER SHARE FROM DISCONTINUED OPERATIONS	$	0.00	$	(0.00	)	$	(0.00	)	$	(0.00	)

WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED		20,236,021,800		20,056,021,800			20,164,415,961			20,047,021,800